AMH and breast carcinoma: Invariably, AMH levels seem to fall to almost zero during chemotherapy regardless of treatment and the post-chemotherapy levels in the ASTRRA trial (82 participants) seem to be an accurate predictor (86.7%) of the recovery of ovarian function during resumption of menstruation in breast cancer patients [79].